Biological effects of growth hormone on carbohydrate and lipid metabolism

Growth Hormone and IGF Research

Volumn 20, Issue 1, 2010, Pages 1-7

  Vijayakumar, Archana ^a   Novosyadlyy, Ruslan ^a   Wu, YingJie ^a   Yakar, Shoshana ^a   LeRoith, Derek ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Carbohydrate; GH; Insulin resistance; Lipids; Metabolism

Indexed keywords

GROWTH HORMONE; INSULIN; LIPOPROTEIN LIPASE; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADIPOSE TISSUE; CARBOHYDRATE METABOLISM; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOLYSIS; LIVER; METABOLIC REGULATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; CARBOHYDRATE METABOLISM; FEMALE; GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIPID METABOLISM; LIVER; MALE; MICE; MUSCLE, SKELETAL; PROTEINS; RATS; SIGNAL TRANSDUCTION;

EID: 74649087362     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2009.09.002     Document Type: Review

References (128)

1. Szego C.M., and White A. The influence of purified growth hormone on fasting metabolism. J. Clin. Endocrinol. Metab. 8 (1948) 594
2. Li C.H., and Evans H.M. The isolation of pituitary growth hormone. Science 99 (1944) 183-184
3. Baumann G., Shaw M., Amburn K., et al. Heterogeneity of circulating growth hormone. Nucl. Med. Biol. 21 (1994) 369-379
4. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
5. Tuggle C.K., and Trenkle A. Control of growth hormone synthesis. Domest. Anim. Endocrinol. 13 (1996) 1-33
6. Chowen J.A., Frago L.M., and Argente J. The regulation of Gh secretion by sex steroids. Eur. J. Endocrinol. 151 Suppl. 3 (2004) U95-U100
7. Meinhardt U.J., and Ho K.K. Regulation of growth hormone action by gonadal steroids. Endocrinol. Metab. Clin. North Am. 36 (2007) 57-73
8. Geary M.P., Pringle P.J., Rodeck C.H., Kingdom J.C., and Hindmarsh P.C. Sexual dimorphism in the growth hormone and insulin-like growth factor axis at birth. J. Clin. Endocrinol. Metab. 88 (2003) 3708-3714
9. Shapiro B.H., Agrawal A.K., and Pampori N.A. Gender differences in drug metabolism regulated by growth hormone. Int. J. Biochem. Cell Biol. 27 (1995) 9-20
10. LeRoith D., and Roberts Jr. C.T. Insulin-like growth factors. Ann. NY Acad. Sci. 692 (1993) 1-9
11. LeRoith D. Insulin-like growth factor receptors binding proteins. Baillieres Clin. Endocrinol. Metab. 10 (1996) 49-73
12. Salmon Jr. W.D., and Daughaday W.H. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J. Lab. Clin. Med. 49 (1957) 825-836
13. Le Roith D., Bondy C., Yakar S., Liu J.L., and Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 22 (2001) 53-74
14. Pennisi P., Gavrilova O., Setser-Portas J., et al. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus. Endocrinology 147 (2006) 2619-2630
15. Simpson H.L., Jackson N.C., Shojaee-Moradie F., et al. Insulin-like growth factor I has a direct effect on glucose and protein metabolism but no effect on lipid metabolism in type 1 diabetes. J. Clin. Endocrinol. Metab. 89 (2004) 425-432
16. Clemmons D.R., Moses A.C., Sommer A., et al. Rh/Igf-I/Rhigfbp-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose. Growth Horm. IGF Res. 15 (2005) 265-274
17. Yamashita S., and Melmed S. Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. J. Clin. Invest. 79 (1987) 449-452
18. Yamashita S., Ong J., and Melmed S. Regulation of human growth hormone gene expression by insulin-like growth factor I in transfected cells. J. Biol. Chem. 262 (1987) 13254-13257
19. Fain J.N. Insulin secretion and action. Metabolism 33 (1984) 672-679
20. Saltiel A.R., and Kahn C.R. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414 (2001) 799-806
21. Gent J., van Kerkhof P., Roza M., Bu G., and Strous G.J. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc. Natl. Acad. Sci. USA 99 (2002) 9858-9863
22. Goffin V., and Kelly P.A. The prolactin/growth hormone receptor family: structure/function relationships. J. Mammary Gland Biol. Neoplasia 2 (1997) 7-17
23. Yang N., Wang X., Jiang J., and Frank S.J. Role of the growth hormone (Gh) receptor transmembrane domain in receptor predimerization and Gh-induced activation. Mol. Endocrinol. 21 (2007) 1642-1655
24. Ram P.A., Park S.H., Choi H.K., and Waxman D.J. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation. J. Biol. Chem. 271 (1996) 5929-5940
25. Smit L.S., Meyer D.J., Billestrup N., Norstedt G., Schwartz J., and Carter-Su C. The role of the growth hormone (Gh) receptor and Jak1 and Jak2 kinases in the activation of Stats 1, 3, and 5 by Gh. Mol. Endocrinol. 10 (1996) 519-533
26. Hansen J.A., Lindberg K., Hilton D.J., Nielsen J.H., and Billestrup N. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins. Mol. Endocrinol. 13 (1999) 1832-1843
27. Lanning N.J., and Carter-Su C. Recent advances in growth hormone signaling. Rev. Endocr. Metab. Disord. 7 (2006) 225-235
28. Youngren J.F. Regulation of insulin receptor function. Cell. Mol. Life Sci. 64 (2007) 873-891
29. Thirone A.C., Carvalho C.R., and Saad M.J. Growth hormone stimulates the tyrosine kinase activity of Jak2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in Rat tissues. Endocrinology 140 (1999) 55-62
30. Love D.W., Whatmore A.J., Clayton P.E., and Silva C.M. Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific. Endocrinology 139 (1998) 1965-1971
31. Dinerstein-Cali H., Ferrag F., Kayser C., Kelly P.A., and Postel-Vinay M. Growth hormone (Gh) induces the formation of protein complexes involving Stat5, Erk2, Shc and serine phosphorylated proteins. Mol. Cell. Endocrinol. 166 (2000) 89-99
32. Zhu T., Ling L., and Lobie P.E. Identification of a Jak2-independent pathway regulating growth hormone (Gh)-stimulated P44/42 mitogen-activated protein kinase activity. Gh activation of Ral and phospholipase D is Src-dependent. J. Biol. Chem. 277 (2002) 45592-45603
33. Jin H., Lanning N.J., and Carter-Su C. Jak2, but not Src family kinases, is required for Stat, Erk, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells. Mol. Endocrinol. 22 (2008) 1825-1841
34. Huang T.T., Du M., Kuluz J.W., Li Y., and Ma H. Postreceptor crosstalk on Pi3k/Akt between Gh and insulin in non-catch-up growth rats born small for gestational age. Horm. Res. 70 (2008) 29-35
35. Huang Y., Kim S.O., Yang N., Jiang J., and Frank S.J. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements. Mol. Endocrinol. 18 (2004) 1471-1485
36. Le M.N., Kohanski R.A., Wang L.H., and Sadowski H.B. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor. Mol. Endocrinol. 16 (2002) 2764-2779
37. Rui L., Yuan M., Frantz D., Shoelson S., and White M.F. Socs-1 and Socs-3 block insulin signaling by ubiquitin-mediated degradation of Irs1 and Irs2. J. Biol. Chem. 277 (2002) 42394-42398
38. Ueki K., Kondo T., and Kahn C.R. Suppressor of cytokine signaling 1 (Socs-1) and Socs-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell. Biol. 24 (2004) 5434-5446
39. Chen X.L., Lee K., Hartzell D.L., et al. Adipocyte insensitivity to insulin in growth hormone-transgenic mice. Biochem. Biophys. Res. Commun. 283 (2001) 933-937
40. Nam S.Y., Kim K.R., Cha B.S., et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 1101-1107
41. Berryman D.E., List E.O., Coschigano K.T., Behar K., Kim J.K., and Kopchick J.J. Comparing adiposity profiles in three mouse models with altered Gh signaling. Growth Horm. IGF Res. 14 (2004) 309-318
42. Pasarica M., Zachwieja J.J., Dejonge L., Redman S., and Smith S.R. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity. J. Clin. Endocrinol. Metab. 92 (2007) 4265-4270
43. Freda P.U., Shen W., Heymsfield S.B., et al. Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J. Clin. Endocrinol. Metab. 93 (2008) 2334-2343
44. Plockinger U., and Reuter T. Pegvisomant increases intra-abdominal fat in patients with acromegaly: a pilot study. Eur. J. Endocrinol. 158 (2008) 467-471
45. Berryman D.E., List E.O., Kohn D.T., Coschigano K.T., Seeley R.J., and Kopchick J.J. Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 147 (2006) 2801-2808
46. Johansen T., Richelsen B., Hansen H.S., Din N., and Malmlof K. Growth hormone-mediated breakdown of body fat: effects of Gh on lipases in adipose tissue and skeletal muscle of old rats fed different diets. Horm. Metab. Res. 35 (2003) 243-250
47. Ng F.M., Jiang W.J., Gianello R., Pitt S., and Roupas P. Molecular and cellular actions of a structural domain of human growth hormone (Aod9401) on lipid metabolism in Zucker fatty rats. J. Mol. Endocrinol. 25 (2000) 287-298
48. Samra J.S., Clark M.L., Humphreys S.M., et al. Suppression of the nocturnal rise in growth hormone reduces subsequent lipolysis in subcutaneous adipose tissue. Eur. J. Clin. Invest. 29 (1999) 1045-1052
49. Richelsen B., Pedersen S.B., Kristensen K., et al. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism 49 (2000) 906-911
50. Khalfallah Y., Sassolas G., Borson-Chazot F., Vega N., and Vidal H. Expression of insulin target genes in skeletal muscle and adipose tissue in adult patients with growth hormone deficiency: effect of one year recombinant human growth hormone therapy. J. Endocrinol. 171 (2001) 285-292
51. Fain J.N., Cheema P., Tichansky D.S., and Madan A.K. Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone. Mol. Cell. Endocrinol. 295 (2008) 101-105
52. Yang S., Mulder H., Holm C., and Eden S. Effects of growth hormone on the function of beta-adrenoceptor subtypes in rat adipocytes. Obes. Res. 12 (2004) 330-339
53. Yip R.G., and Goodman H.M. Growth hormone and dexamethasone stimulate lipolysis and activate adenylyl cyclase in rat adipocytes by selectively shifting Gi Alpha2 to lower density membrane fractions. Endocrinology 140 (1999) 1219-1227
54. Lonnqvist F., Krief S., Strosberg A.D., Nyberg S., Emorine L.J., and Arner P. Evidence for a functional beta 3-adrenoceptor in man. Br. J. Pharmacol. 110 (1993) 929-936
55. Oscarsson J., Ottosson M., and Eden S. Effects of growth hormone on lipoprotein lipase and hepatic lipase. J. Endocrinol. Invest. 22 (1999) 2-9
56. Oscarsson J., Ottosson M., Johansson J.O., et al. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (Gh) in Gh-deficient adults. Ii. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabolism 45 (1996) 370-377
57. Farnier C., Krief S., Blache M., et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/Erk signalling pathway. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 1178-1186
58. Fleenor D., Arumugam R., and Freemark M. Growth hormone and prolactin receptors in adipogenesis: Stat-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm. Res. 66 (2006) 101-110
59. Stewart W.C., Baugh Jr. J.E., Floyd Z.E., and Stephens J.M. Stat 5 activators can replace the requirement of Fbs in the adipogenesis of 3t3-L1 cells. Biochem. Biophys. Res. Commun. 324 (2004) 355-359
60. Kawai M., Namba N., Mushiake S., et al. Growth hormone stimulates adipogenesis of 3t3-L1 cells through activation of the Stat5a/5b-Ppargamma pathway. J. Mol. Endocrinol. 38 (2007) 19-34
61. Hennighausen L., and Robinson G.W. Interpretation of cytokine signaling through the transcription factors Stat5a and Stat5b. Genes Dev. 22 (2008) 711-721
62. Tai P.K., Liao J.F., Chen E.H., Dietz J., Schwartz J., and Carter-Su C. Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3t3-F442a adipose cells. J. Biol. Chem. 265 (1990) 21828-21834
63. Kilgour E., Baldwin S.A., and Flint D.J. Divergent regulation of rat adipocyte Glut1 and Glut4 glucose transporters by Gh. J. Endocrinol. 145 (1995) 27-33
64. del Rincon J.P., Iida K., Gaylinn B.D., et al. Growth hormone regulation of P85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56 (2007) 1638-1646
65. Barbour L.A., Mizanoor Rahman S., Gurevich I., et al. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J. Biol. Chem. 280 (2005) 37489-37494
66. Silha J.V., Krsek M., Hana V., et al. Leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin. Endocrinol. (Oxf.) 58 (2003) 736-742
67. Lanes R., Soros A., Gunczler P., et al. Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins. J. Pediatr. 149 (2006) 324-329
68. Joaquin C., Aguilera E., Granada M.L., et al. Leptin and pregnancy-associated plasma protein-A. Eur. J. Endocrinol. 158 (2008) 483-490
69. Veldhuis J.D., Hudson S.B., Erickson D., Bailey J.N., Reynolds G.A., and Bowers C.Y. Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women. Am. J. Physiol. Endocrinol. Metab. 297 (2009) E367-E374
70. Veldhuis J.D., Keenan D.M., Bailey J.N., Adeniji A.M., Miles J.M., and Bowers C.Y. Novel relationships of age, visceral adiposity, insulin-like growth factor (Igf)-I and Igf binding protein concentrations to growth hormone (Gh) releasing-hormone and Gh releasing-peptide efficacies in men during experimental hypogonadal clamp. J. Clin. Endocrinol. Metab. 94 (2009) 2137-2143
71. Nilsson L., Binart N., Bohlooly Y.M., et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem. Biophys. Res. Commun. 331 (2005) 1120-1126
72. Wang Z., Al-Regaiey K.A., Masternak M.M., and Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 323-331
73. Delhanty P.J., Mesotten D., McDougall F., and Baxter R.C. Growth hormone rapidly induces resistin gene expression in white adipose tissue of spontaneous dwarf (Sdr) rats. Endocrinology 143 (2002) 2445-2448
74. Chiba T., Yamaza H., Komatsu T., et al. Pituitary growth hormone suppression reduces resistin expression and enhances insulin effectiveness: relationship with caloric restriction. Exp. Gerontol. 43 (2008) 595-600
75. Nozue H., Kamoda T., and Matsui A. Serum resistin concentrations in growth hormone-deficient children during growth hormone replacement therapy. Metabolism 56 (2007) 1514-1517
76. Hoogerbrugge N., Jansen H., Staels B., Seip M.J., and Birkenhager J.C. Growth hormone normalizes hepatic lipase in hypothyroid rat liver. Metabolism 42 (1993) 669-671
77. Neve B.P., Hoogerbrugge N., Verhoeven A.J., Birkenhager J.C., and Jansen H. Growth hormone restores hepatic lipase Mrna levels but the translation is impaired in hepatocytes of hypothyroid rats. Biochim. Biophys. Acta 1345 (1997) 172-179
78. Wang Z., Masternak M.M., Al-Regaiey K.A., and Bartke A. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148 (2007) 2845-2853
79. Szendroedi J., Zwettler E., Schmid A.I., et al. Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly. PLoS One 3 (2008) e3958
80. Jalouli M., Carlsson L., Ameen C., et al. Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. Endocrinology 144 (2003) 101-109
81. Masternak M.M., Al-Regaiey K.A., Del Rosario Lim M.M., et al. Effects of caloric restriction and growth hormone resistance on the expression level of peroxisome proliferator-activated receptors superfamily in liver of normal and long-lived growth hormone receptor/binding protein knockout mice. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005) 1394-1398
82. Ljungberg A., Linden D., Ameen C., Bergstrom G., and Oscarsson J. Importance of Ppar alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism. Growth Horm. IGF Res. 17 (2007) 154-164
83. Olsson B., Bohlooly Y.M., Brusehed O., et al. Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E504-E511
84. Cui Y., Hosui A., Sun R., et al. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 46 (2007) 504-513
85. Ghanaat F., and Tayek J.A. Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers. Metabolism 54 (2005) 604-609
86. Hoybye C., Chandramouli V., Efendic S., et al. Contribution of gluconeogenesis and glycogenolysis to hepatic glucose production in acromegaly before and after pituitary microsurgery. Horm. Metab. Res. 40 (2008) 498-501
87. Kaplan W., Sunehag A.L., Dao H., and Haymond M.W. Short-term effects of recombinant human growth hormone and feeding on gluconeogenesis in humans. Metabolism 57 (2008) 725-732
88. Brooks N.L., Trent C.M., Raetzsch C.F., et al. Low utilization of circulating glucose after food withdrawal in snell dwarf mice. J. Biol. Chem. 282 (2007) 35069-35077
89. Fan Y., Menon R.K., Cohen P., et al. Liver-specific deletion of the growth hormone receptor reveals essential role of Gh signaling in hepatic lipid metabolism. J. Biol. Chem. (2009)
90. Cho Y., Ariga M., Uchijima Y., et al. The novel roles of liver for compensation of insulin resistance in human growth hormone transgenic rats. Endocrinology 147 (2006) 5374-5384
91. Dominici F.P., Hauck S., Argentino D.P., Bartke A., and Turyn D. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (Irs)-1 and Irs-2 in liver of Ames dwarf mice. J. Endocrinol. 173 (2002) 81-94
92. Oscarsson J., Ottosson M., Vikman-Adolfsson K., et al. Gh but Not Igf-I or insulin increases lipoprotein lipase activity in muscle tissues of hypophysectomised rats. J. Endocrinol. 160 (1999) 247-255
93. Krag M.B., Gormsen L.C., Guo Z., et al. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered Vldl-triglyceride kinetics. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E920-E927
94. Trepp R., Fluck M., Stettler C., et al. Effect of Gh on human skeletal muscle lipid metabolism in Gh deficiency. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E1127-E1134
95. Sjogren K., Leung K.C., Kaplan W., Gardiner-Garden M., Gibney J., and Ho K.K. Growth hormone regulation of metabolic gene expression in muscle: a microarray study in hypopituitary men. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E364-E371
96. Mauras N., O'Brien K.O., Welch S., et al. Insulin-like growth factor I and growth hormone (Gh) treatment in Gh-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J. Clin. Endocrinol. Metab. 85 (2000) 1686-1694
97. Short K.R., Moller N., Bigelow M.L., Coenen-Schimke J., and Nair K.S. Enhancement of muscle mitochondrial function by growth hormone. J. Clin. Endocrinol. Metab. 93 (2008) 597-604
98. Kim D.S., Itoh E., Iida K., and Thorner M.O. Growth hormone increases Mrna levels of Ppardelta mice and Foxo1 in skeletal muscle of growth hormone deficient Lit/Lit. Endocr. J. (2008)
99. Klover P., and Hennighausen L. Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/B in muscle: a role for autocrine/paracrine insulin-like growth factor I. Endocrinology 148 (2007) 1489-1497
100. Christopher M., Hew F.L., Oakley M., Rantzau C., and Alford F. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. J. Clin. Endocrinol. Metab. 83 (1998) 1668-1681
101. Borst S.E., Snellen H.G., Ross H., Scarpace P.J., and Kim Y.W. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats. Biochem. Biophys. Res. Commun. 291 (2002) 722-726
102. Dominici F.P., Argentino D.P., Bartke A., and Turyn D. The dwarf mutation decreases high dose insulin responses in skeletal muscle, the opposite of effects in liver. Mech. Ageing. Dev. 124 (2003) 819-827
103. Robertson K., Kopchick J.J., and Liu J.L. Growth hormone receptor gene deficiency causes delayed insulin responsiveness in skeletal muscles without affecting compensatory islet cell overgrowth in obese mice. Am. J. Physiol. Endocrinol. Metab. 291 (2006) E491-E498
104. Yakar S., Liu J.L., Stannard B., et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 96 (1999) 7324-7329
105. Deschenes M.R. Effects of aging on muscle fibre type and size. Sports Med. 34 (2004) 809-824
106. Marzetti E., Anne Lees H., Eva Wohlgemuth S., and Leeuwenburgh C. Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction. Biofactors 35 (2009) 28-35
107. Sotiropoulos A., Ohanna M., Kedzia C., et al. Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor I up-regulation. Proc. Natl. Acad. Sci. USA 103 (2006) 7315-7320
108. Kim H., Barton E., Muja N., Yakar S., Pennisi P., and Leroith D. Intact insulin and insulin-like growth factor-I receptor signaling is required for growth hormone effects on skeletal muscle growth and function in vivo. Endocrinology 146 (2005) 1772-1779
109. Segard H.B., Moulin S., Boumard S., Augier de Cremiers C., Kelly P.A., and Finidori J. Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2c12 myoblasts. Cell Signal. 15 (2003) 615-623
110. Bogazzi F., Russo D., Raggi F., et al. Transgenic mice overexpressing growth hormone (Gh) have reduced or increased cardiac apoptosis through activation of multiple Gh-dependent or -independent cell death pathways. Endocrinology 149 (2008) 5758-5769
111. Marzetti E., Groban L., Wohlgemuth S.E., et al. Effects of short-term Gh supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R558-R567
112. Nass R., Johannsson G., Christiansen J.S., Kopchick J.J., and Thorner M.O. The aging population - is there a role for endocrine interventions?. Growth Horm. IGF Res. 19 (2009) 89-100
113. Clark R.P., Schuenke M., Keeton S.M., Staron R.S., and Kopchick J.J. Effects of growth hormone and insulin-like growth factor I on muscle in mouse models of human growth disorders. Horm. Res. 66 Suppl. 1 (2006) 26-34
114. Lindberg-Larsen R., Moller N., Schmitz O., et al. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly. J. Clin. Endocrinol. Metab. 92 (2007) 1724-1728
115. Mauras N., and Haymond M.W. Are the metabolic effects of Gh and Igf-I separable?. Growth Horm. IGF Res. 15 (2005) 19-27
116. Giovannini S., Marzetti E., Borst S.E., and Leeuwenburgh C. Modulation of Gh/Igf-1 axis: potential strategies to counteract sarcopenia in older adults. Mech. Ageing Dev. 129 (2008) 593-601
117. Gibney J., Wolthers T., Burt M.G., Leung K.C., Umpleby A.M., and Ho K.K. Protein metabolism in acromegaly: differential effects of short- and long-term treatment. J. Clin. Endocrinol. Metab. 92 (2007) 1479-1484
118. Sharp Z.D., and Bartke A. Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (Pi3k/Akt/Mtor)-dependent translation regulatory signaling pathways in Ames dwarf mice. J. Gerontol. A Biol. Sci. Med. Sci. 60 (2005) 293-300
119. Norrelund H., Riis A.L., and Moller N. Effects of Gh on protein metabolism during dietary restriction in man. Growth Horm. IGF Res. 12 (2002) 198-207
120. Moller N., Copeland K.C., and Nair K.S. Growth hormone effects on protein metabolism. Endocrinol. Metab. Clin. North Am. 36 (2007) 89-100
121. Hayashi A.A., and Proud C.G. The rapid activation of protein synthesis by growth hormone requires signaling through Mtor. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E1647-E1655
122. Tsai T.F., Yauk Y.K., Chou C.K., et al. Evidence of autocrine regulation in human hepatoma cell lines. Biochem. Biophys. Res. Commun. 153 (1988) 39-45
123. Kovacs P., and Stumvoll M. Fatty acids and insulin resistance in muscle and liver. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005) 625-635
124. Yakar S., Liu J.L., Fernandez A.M., et al. Liver-specific Igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50 (2001) 1110-1118
125. Yakar S., Setser J., Zhao H., et al. Inhibition of growth hormone action improves insulin sensitivity in liver Igf-1-deficient mice. J. Clin. Invest. 113 (2004) 96-105
126. Lebrun P., and Van Obberghen E. Socs proteins causing trouble in insulin action. Acta Physiol. (Oxf.) 192 (2008) 29-36
127. Mauvais-Jarvis F., Ueki K., Fruman D.A., et al. Reduced expression of the murine P85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Invest. 109 (2002) 141-149
128. Ueki K., Fruman D.A., Brachmann S.M., Tseng Y.H., Cantley L.C., and Kahn C.R. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol. Cell. Biol. 22 (2002) 965-977